Evidence map›Paper›PMID 40567895›Full record

ArticleNeuroimage. Reports2025

Enhancing precision in multiple sclerosis lesion segmentation: A U-net based machine learning approach with data augmentation.

Oezdemir Cetin, Berkay Canel, Gamze Dogali, Unal Sakoglu

Abstract read
In one paragraph

Article in Neuroimage. Reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oezdemir CetinDepartment of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany.
Berkay CanelDepartment of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany.
Gamze DogaliDepartment of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany.
Unal SakogluComputer Engineering, University of Houston - Clear Lake, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Segmentation of Multiple Sclerosis (MS) lesions from Magnetic Resonance Imaging (MRI) data presents a significant challenge due to the necessity for large volumes of training data and a sophisticated training process. Traditional MRI datasets often lack the extensive sample sizes required for effective training, necessitating the exploration of alternative methods for accurate segmentation. This study proposes a robust machine learning algorithm designed to identify MS lesions using both single-modal and multi-modal MRI data. The proposed algorithm employs Convolutional Neural Networks (CNNs) in the form of U-Net architecture, a renowned model for biomedical image segmentation. To address the issue of insufficient training data, data augmentation techniques have been implemented, enhancing the diversity and volume of the training set. The dataset for this study was created from MRI data of 20 subjects. The algorithm's effectiveness was evaluated using the DSC score, a statistical tool that measures the similarity between two samples. The model achieved a DSC score of 0.7960 in the training set and 0.7912 in the test set, demonstrating its effectiveness in performing segmentation of MS from multi-modal MRI data. The predicted locations of MS lesions were compared with the corresponding layers of white matter, gray matter, and cerebrospinal fluid within the brain. This innovative approach aims to enhance the accuracy and efficiency of MS lesion segmentation, contributing to advancements in precision medicine and the overall understanding of MS.

Indexed as

Lesion detectionMulti-modal MRIMultiple sclerosisSegmentationU-Net

Identifiers

PMID40567895
PMCPMC12172712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.